Health
FDA authorizes marketing of new device designed to remove dead pancreatic tissue – FDA.gov
): FDA granted de novo for the EndoRotor System to resection (cut out) and remove necrotic (dead) tissue for patients with walled-off pancreatic necrosis.
For Immediate Release:
December 23, 2020
Today, the U.S. Food and Drug Administration authorized marketing of the EndoRotor System to resect (cut out) and remove necrotic (dead) tissue for patients with walled-off pancreatic necrosis (WOPN), a potentially deadly condition which can occur several weeks after an episode of severe acute pancreatitis, often requiring tissue removal.
This device has shown its potential to provide a minimally invasive way to remove harmful necrotic pancreatic tissue…
-
Business24 hours agoForget CBA and buy these high-yield ASX dividend shares
-
Noosa News21 hours agoMan dies after stabbing in inner-city unit
-
Noosa News24 hours agoThe Almond Ashes sees Australia and India mix business and cricket
-
General24 hours agoUK PM ready to ‘shelter’ businesses from tariff storm